Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer

Genetic profiling of urine cell free DNA (cfDNA) has not been evaluated in advanced prostate cancer. We performed whole genome sequencing of urine cfDNAs to identify tumor-associated copy number variations in urine before and after initiating androgen deprivation therapy in HSPC stage and docetaxel...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Xia, Yun, Huang, Chiang-Ching, Dittmar, Rachel, Du, Meijun, Wang, Yuan, Liu, Hongyan, Shenoy, Niraj, Wang, Liang, Kohli, Manish
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5094965/
https://ncbi.nlm.nih.gov/pubmed/27127882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9027
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares